Investing in Cumberland Pharmaceuticals Inc. (CPIX)  ➔  Intrinsic value

Prev. close$2.74 
ModelValueUpside
Chepakovich$1.51-45%
Graham-Dodd$0.09-97%
Graham$0.00-100%
Previous Close$2.74  
Valuation MethodValuePotential 
Chepakovich Model$1.51-45%recalculate
Graham-Dodd$0.09-97%recalculate
Graham Formula$0.00-100%recalculate

Latest news

Company description

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care and gastroenterology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative, for the treatment of chronic and acute constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol injection for treating hyponatremia; and Vibativ injection, for the treatment of certain serious bacterial infections. It also develops RediTrex injection for the treatment of active rheumatoid, juvenile idiopathic, and severe psoriatic arthritis, as well as severe disabling psoriasis. The company markets and sells its products through sales representatives and district managers. Cumberland Pharmaceuticals Inc. has a strategic alliance with Clinigen Group plc and Nordic Group B.V. The company was incorporated in 1999 and is headquartered in Nashville, Tennessee.